Trials / Completed
CompletedNCT02412501
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Medtronic Vascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to assess the safety and efficacy of the Resolute Onyx Zotarolimus-Eluting Coronary Stent System for the treatment of de novo lesions in native coronary arteries that allows the use of a 2.0 mm diameter stent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Resolute Onyx Stent - 2.0 mm | Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent |
Timeline
- Start date
- 2015-04-06
- Primary completion
- 2017-02-13
- Completion
- 2019-02-21
- First posted
- 2015-04-09
- Last updated
- 2019-07-02
- Results posted
- 2018-04-10
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02412501. Inclusion in this directory is not an endorsement.